Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-08-27
Original SEC Filing: Click here

---

Webplus: SVA/20140827/6-K/2_EX-99.1/000.htm SEC Original: v387841_ex99-1.htm
BEIJING, Aug. 27, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company’s 2014 Annual General Meeting of Shareholders held on Wednesday, August 27, 2014 in Beijing, PRC. The required quorum, a majority of the common shares outstanding, was voted by proxy. The Company’s shareholders approved the following

---

---

Webplus: SVA/20140827/6-K/1/000.htm SEC Original: v387841_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-08-27CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085